Linezolid induces ring sideroblasts

Haematologica

Volumn 98, Issue 11, 2013, Pages

  Willekens, Christophe ^a,b   Dumezy, Florent ^a   Boyer, Thomas ^a,b   Renneville, Aline ^a   Rossignol, Julien ^a   Berthon, Céline ^a,c   Cotteau Leroy, Angélique ^a   Mehiaoui, Lotfi ^a   Quesnel, Bruno ^a,b,c   Preudhomme, Claude ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

Author keywords

Hematologic toxicity; Linezolid; Ring sideroblasts; Sideroblastic anemia

Indexed keywords

BUSULFAN; CHLORAMPHENICOL; ISONIAZID; LINEZOLID; PENICILLAMINE;

DYSERYTHROPOIESIS; ERYTHROID PRECURSOR CELL; GENE; GENE MUTATION; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; NONHUMAN; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RING SIDEROBLAST; SF3B1 GENE; SIDE EFFECT; SIDEROBLASTIC ANEMIA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

HEMATOLOGIC TOXICITY; LINEZOLID; RING SIDEROBLASTS; SIDEROBLASTIC ANEMIA;

ACETAMIDES; ADULT; AGED; ANEMIA, SIDEROBLASTIC; ANTI-INFECTIVE AGENTS; BONE MARROW CELLS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; RETROSPECTIVE STUDIES;

EID: 84887009254     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.092395     Document Type: Letter

References (15)

1. Soriano A, Miró O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med. 2005; 353(21): 2305-6.
2. Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell. 2007; 26(3): 393-402.
3. Cazzola M, Invernizzi R. Ring sideroblasts and sideroblastic anemias. Haematologica. 2011; 96(6): 789-92.
4. Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, et al. Diagnosis and classification of myelodysplastic syndrome: international working group on morphology of myelodysplastic syndrome (iwgm-mds) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 2008; 93(11): 1712-7.
5. Cuijpers MLH, Raymakers RAP, Mackenzie MA, de Witte TJM, Swinkels DW. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. Br J Haematol. 2010; 149(3): 322-33.
6. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic sf3b1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011; 365(15): 1384-95.
7. Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, et al. Sf3b1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood. 2012; 120(16): 3173-86.
8. Lund JE, Brown PK. Hypersegmented megakaryocytes and megakaryocytes with multiple separate nuclei in dogs treated with pnu-100592, an oxazolidinone antibiotic. Toxicol Pathol. 1997; 25(4): 339-43.
9. Montpetit MC, Shammo JL, Loew J, Dunlap S, Pamboukian SV, Heroux A. Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device. J Heart Lung Transplant. 2004; 23 (9): 1119-22.
10. Kakimoto T, Nakazato T, Miura R, Kurai H, Yamashita D, Sagara Y, et al. [Sideroblastic anemia after prolonged linezolid therapy]. Rinsho Ketsueki. 2008; 49(11): 1566-8.
11. Dawson MA, Davis A, Elliott P, Cole-Sinclair M. Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited. Intern Med J. 2005; 35(10): 626-8.
12. Abena PA, Mathieux VG, Scheiff JM, Michaux LM, Vandercam BC. Linezolid and reversible myelosuppression. JAMA. 2001; 286(16): 1973; author reply 1974.
13. Saini N, Jacobson JO, Jha S, Saini V, Weinger R. The perils of not digging deep enough-uncovering a rare cause of acquired anemia. Am J Hematol. 2012; 87(4): 413-6.
14. Ammus S, Yunis AA. Drug-induced red cell dyscrasias. Blood Rev. 1989; 3(2): 71-82.
15. Fernandez LA, Zayed E. Busulfan-induced sideroblastic anemia. Am J Hematol. 1988; 28(3): 199-200.